The Stem Cell Innovations (SCI) team claim that their solution will run on two blockchain platforms. The first platform will be built on Ethereum and will be used only for ERC20 tokens. The second custom blockchain will be developed by the SCI engineers specifically for the healthcare environment. Via the SCI app users will be able to buy cord blood services, purchase medical supplies, acquire synthetic stem cells, etc. The ERC20 SCIA tokens will be used to access and pay for the platform services.